Mechanisms of B Cell Responses in Autoimmune Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituxibab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)


Awarded By

Total Award Amount

  • 474690.00
  • Direct Costs

  • 394282.00
  • Sponsor Award Id

  • C10
  • Contributor

  • Robert Bourge   Principal Investigator